Ursprung des Netzwerks ersten Grades von Mary Jenkins
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mary Jenkins
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Corporate Secretary | |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BAXALTA INC | Biotechnology | President | |
Shire US, Inc.
 Shire US, Inc. Medical DistributorsDistribution Services Shire US, Inc. sells and markets prescription medicines. The company was founded on September 28, 1983 and is headquartered in Lexington, MA. | Medical Distributors | Director/Board Member President | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Director/Board Member | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Franklin Pierce University | College/University | Undergraduate Degree | |
Lotus Tissue Repair, Inc.
 Lotus Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Lotus Tissue Repair, Inc. develops dermatologic treatment technologies. Its solutions include a protein replacement therapy for the treatment of dystrophic epidermolysis bullosa, a group of genetic skin disease. The company was founded by Mei Chen, Mark P. de Souza, Philip R. Reilly, David Woodley and James W. Fordyce in 2011 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 11 |
Sektoral
| Health Technology | 9 |
| Distribution Services | 2 |
| Consumer Services | 2 |
Operativ
| Director/Board Member | 7 |
| Corporate Secretary | 6 |
| President | 3 |
| Treasurer | 2 |
| Director of Finance/CFO | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Colleen Tupper | 7 |
| Jason E. Baranski | 6 |
- Börse
- Insiders
- Mary Jenkins
- Unternehmensverbindungen
